seqWell

Website

seqWell Inc.

1 Investors
Biotechnology
BEVERLY, MA

seqWell Inc. is a biotechnology company dedicated to advancing the efficiency and accuracy of DNA/RNA library preparation workflows for next-generation sequencing (NGS). By pioneering innovative solutions, seqWell streamlines complex processes, making genetic testing more accessible and reliable for laboratories worldwide.

Products & Team

ExpressPlex™

Library Preparation SolutionSeed

ExpressPlex™ is a revolutionary product from seqWell that simplifies the traditional library preparation workflows for sequencing, integrating multiple procedural steps into a single streamlined process. This product enhances quality control measures and supports a wide range of sequencing applications with improved efficiency and reduced complexity.

Value Proposition

ExpressPlex™ solves the problem of complex and error-prone traditional library preparation methods by enabling faster and more reliable workflows, which is crucial for high-throughput genomic testing.

Pain Points

Customers face challenges with complicated and error-prone genetic sequencing workflows, and require solutions that offer faster processing times and reliable results across a range of pathogens.

Simplified library prepCombines 3-4 steps into one processEnhanced quality controlVersatile across various sequencing applications
Industry
Other Technology
Primary business sector
Founded
2025
Year established
Location
BEVERLY, MA
Primary headquarters

Funding History

Total Raised:
$3.1M
E

Option to Acquire, Security Offering

Closed
January 2025
$11.5K
Raised
Progress
100%
Raised
$11.5K
Target
$11.5K
#000167972025000001
E

Equity Offering

September 2024
$3.5M
Target
Progress
88%
Raised
$3.1M
Target
$3.5M
#000167972025000002